Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02669407 · ClinicalTrials.gov registry record · NA
Splanchnic Nerve Anesthesia in Heart Failure
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02669407 is a NA study that has completed, run by Duke University. The registered enrollment target is 14 participants.
The verdict
NCT02669407, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Patients admitted for acute heart failure and undergoing right heart catheterization will be enrolled in this study. Subjects will undergo catheterization of the heart to obtain central cardiac pressure and other cardiac hemodynamic parameters. Subsequently, the subject will undergo a regional nerve block of the splanchnic nerves. Patients will remain in the catheterization lab for the duration of anesthetic block and will be continuously hemodynamically monitored. This study will be a prospective, uncontrolled clinical trial. The study will not be controlled as invasive monitoring of hemodynamics will be performed, allowing clear demonstration of a cause-effect relationship. The goal of the study is to provide proof of concept.
Interventions
- PROCEDURE splanchnic nerve anesthesia with a local anesthetic
- DRUG regional nerve block with a local anesthetic (Lidocaine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2018-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02669407
The ClinicalTrials.gov registry entry for NCT02669407 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which splanchnic nerve anesthesia with a local anesthetic is the first listed.
NCT02669407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02669407 about?
NCT02669407 is a clinical study titled "Splanchnic Nerve Anesthesia in Heart Failure". Patients admitted for acute heart failure and undergoing right heart catheterization will be enrolled in this study. Subjects will undergo catheterization of the heart to obtain central cardiac pressure and other cardiac hemodynamic parameters. Subsequently, the subject will undergo a regional nerve...
What is the current status of trial NCT02669407?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2017-01-01. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02669407?
The interventions under investigation include: splanchnic nerve anesthesia with a local anesthetic (PROCEDURE), regional nerve block with a local anesthetic (Lidocaine) (DRUG).
Who is sponsoring clinical trial NCT02669407?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.